SCHEMBL6981472

SCHEMBL6981472

CC1CCc2cc(NS(=O)(=O)c3ccccc3)ccc2N1C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
DRD3 P35462 1/20 0.44
HTR6 P50406 1/20 0.44
MAPK1 P28482 1/20 0.43
HDAC1 Q13547 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC4 P56524 1/20 0.42
NR3C1 P04150 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
BRD4 O60885 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TP53 P04637 2/20 0.40
AR P10275 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6983525 0.86 F2 (0.46) MAPK1HDAC1HDAC8HDAC4NR3C1
SCHEMBL6984210 0.83 KMT2A (0.55) DRD2HTR2AHTR2CDRD3HTR6
SCHEMBL6981477 0.83 GAA (0.38) HTR6HDAC1HDAC8HDAC4LMNA
SCHEMBL6984463 0.82 POLB (0.44) DRD2HTR2AHTR2CDRD3HTR6
SCHEMBL6977969 0.82 NR3C1 (0.56) DRD2HTR2AHTR2CDRD3HTR6
SCHEMBL6985317 0.82 NR3C1 (0.58) NR3C1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL6985046 0.81 KMT2A (0.43) DRD2HTR2AHTR2CDRD3HTR6
SCHEMBL6976398 0.78 NR3C1 (0.51) DRD2HTR2AHTR2CDRD3HTR6
SCHEMBL6976880 0.76 NR3C1 (0.55) DRD2HTR2AHTR2CDRD3HTR6
SCHEMBL6985746 0.75 KMT2A (0.56) DRD2HTR2AHTR2CDRD3HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed